Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000211

Director sold 646 shares at $500.00 ($323,000)

  • Director acquired 646 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bhatia Sangeeta N. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-30 Exercise or conversion : show line 1 in the form 10b5-1 +646 $152.74 $98,670 5,081 D
2024-08-30 Sale : show line 2 in the form 10b5-1 −646 $500.00 $323,000 4,435 D
Open-market sales · 646 sh · avg $500.00 · $323,000

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-08-30 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −646 $152.74 2028-05-31 646 0 D
Loading xslF345X05/wk-form4_1725480753.xml…